Find and Pitch Jounalists, Get Your Story Covered

Tags: addiction health addiction | drug development | opioids | Pharmaceuticals | public health | STAT Breakthrough Summit art history drug addiction

	Profile	Recent Articles on Subject
1	Shannon Firth MedPage Today Washington correspondent for MedPageToday. CUNYJschool pride. Healthcarejournalism	Experts Debate the Best Ways to Use Opioid Settlement Funds - 8 days ago Americans Struggling With Addiction, Mental Health, SAMHSA Survey Shows - about 1 year ago
2	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	3 closely watched drugs that failed in the clinic - 10 days ago
3	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Oncology, obesity and more: Where pharma R&D is headed in 2025 - 10 days ago
4	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Up and down the ladder: The latest comings and goings - 13 days ago STAT+: Up and down the ladder: The latest comings and goings - 20 days ago STAT+: Up and down the ladder: The latest comings and goings - about 1 month ago STAT+: Pharmalittle: We’re reading about Trump and tariff worries, PBM rules in New York, and more - about 1 month ago STAT+: Pharma still ‘falling short’ in providing access to low- and middle-income countries, analysis finds - about 1 month ago STAT+: Up and down the ladder: The latest comings and goings - about 2 months ago STAT+: Up and down the ladder: The latest comings and goings - about 2 months ago STAT+: Pharmalittle: We’re reading about pharma risks in China, mitigating shortages, and more - about 2 months ago STAT+: To mitigate drug shortages, a new study suggests looking at Canada - about 2 months ago STAT+: Up and down the ladder: The latest comings and goings - 2 months ago STAT+: Up and down the ladder: The latest comings and goings - 2 months ago STAT+: Up and down the ladder: The latest comings and goings - 3 months ago STAT+: Up and down the ladder: The latest comings and goings - 3 months ago STAT+: Pharmalittle: We’re reading about Moderna R&D cuts, Lilly plant investments and more - 3 months ago STAT+: Up and down the ladder: The latest comings and goings - 4 months ago STAT+: Pharmalittle: We’re reading about Zepbound trial results, an Alnylam heart drug, and more - 4 months ago STAT+: Up and down the ladder: The latest comings and goings - 4 months ago STAT+: Up and down the ladder: The latest comings and goings - 5 months ago STAT+: Pharmalittle: We’re reading about Roche obesity drug data, fallout from the Menendez verdict, and more - 5 months ago STAT+: Up and down the ladder: The latest comings and goings - 6 months ago STAT+: Up and down the ladder: The latest comings and goings - 6 months ago STAT+: Up and down the ladder: The latest comings and goings - 8 months ago STAT+: Pharmalittle: We’re reading about an Amgen obesity drug, a Senate bill on shortages, and more - 8 months ago STAT+: Up and down the ladder: The latest comings and goings - 9 months ago STAT+: Pharmalittle: We’re reading about biotech startups, Pfizer’s RSV vaccine, and more - 9 months ago STAT+: Up and down the ladder: The latest comings and goings - 9 months ago STAT+: Up and down the ladder: The latest comings and goings - 9 months ago STAT+: Pharmalittle: We’re reading about a Lilly obesity-drug ad, a $35 cap on inhalers, and more - 10 months ago STAT+: Pharmalittle: We’re reading about slow uptake of an Alzheimer’s drug, an opioid lawsuit, and more - 11 months ago STAT+: FDA is blasted by advocates for pursuing a deal with data provider that has ties to opioid makers - 12 months ago STAT+: Pharmalittle: FDA approvals rebound, abortion pill orders rise, and more news - 12 months ago
5	Aislinn Antrim, Assistant Managing Editor Pharmacy Times Journalist at Pharmacy Times. UNC graduate. PoliticsStorytellingCats	ASHP Midyear: Opioid Use Disorder in Critically Ill Patients Has Unique Challenges - 18 days ago
6	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	Biotech’s next gold rush, GLP-1 shortages, and STAT Summit highlights - 2 months ago Summit’s upcoming cancer results, Recursion’s mixed data, and the next big obesity target - 4 months ago Listen: Live! From the STAT Breakthrough Summit East - 9 months ago
7	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	Biotech’s next gold rush, GLP-1 shortages, and STAT Summit highlights - 2 months ago More evidence on GLP-1s and opioid addiction - 2 months ago Summit’s upcoming cancer results, Recursion’s mixed data, and the next big obesity target - 4 months ago
8	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	Biotech’s next gold rush, GLP-1 shortages, and STAT Summit highlights - 2 months ago Summit’s upcoming cancer results, Recursion’s mixed data, and the next big obesity target - 4 months ago STAT+: Summit Therapeutics vs. Merck: Prepping for a big lung cancer study reveal - 4 months ago Listen: Live! From the STAT Breakthrough Summit East - 9 months ago STAT Virtual Event \| Cancer’s Breakthrough Engine - about 1 year ago
9	Theresa Gaffney STAT News Audio producer, health reporter. Boston audio productionhealth reporting	Morning Rounds: Highlights from the STAT Summit - 2 months ago
10	Emily Olsen Healthcare Dive Reporter at Healthcare Dive. Loyola, Medill alum. Chicago, Illinois HealthcareNews	Lawmakers urge Biden administration to extend telehealth prescribing flexibilities for opioid use disorder - 3 months ago

Journalists covering addiction | drug development | opioids | Pharmaceuticals | public health | STAT Breakthrough Summit